TriSalus Life Sciences® Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, is ...

The VENUS trial results, which demonstrated a benefit of adding an ethanol infusion to the vein of Marshall during catheter ablation of persistent atrial fibrillation (AF), are now published. The ...

In addition, infusion procedures frequently follow other care appointments, making it a challenge to successfully manage a complex, constantly changing schedule. Solutions based on mathematical ...

Infusion reactions, also known as acute infusion reactions or infusion-related reactions, are common adverse effects that can occur when a person receives medication intravenously. Infusion reactions ...